PAVmed Inc

(NASDAQ:PAVM)

Latest On PAVmed Inc (PAVM):

Date/Time Type Description Signal Details
2023-05-17 20:40 ESTNewsPAVmed (PAVM) Q1 2023 Earnings Call TranscriptN/A
2023-05-16 17:27 ESTNewsPAVmed Non-GAAP EPS of -$0.10 beats by $0.07, revenue of $0.45M beats by $0.22MN/A
2023-03-15 15:12 ESTNewsPAVmed Non-GAAP EPS of -$0.15 beats by $0.04, revenue of $112M beats by $111.32MN/A
2023-03-15 15:12 ESTNewsPAVmed stock dips as net loss widens, revenue shrinks in Q4N/A
2023-03-15 15:12 ESTNewsPAVmed Inc. 2022 Q4 - Results - Earnings Call PresentationN/A
2023-03-15 15:12 ESTNewsPAVmed Inc. (PAVM) Q4 2022 Earnings Call TranscriptN/A
2023-03-14 08:26 ESTNewsPAVmed Q4 2022 Earnings PreviewN/A
2023-01-17 23:01 ESTNewsPAVmed, its units Lucid Diagnostics, Veris Health implement strategic changes, layoffsN/A
2022-12-15 14:01 ESTNewsPAVmed Digital Health subsidiary launches Veris cancer care platformN/A
2022-11-15 23:25 ESTNewsPAVmed GAAP EPS of -$0.29N/A
2022-11-15 23:25 ESTNewsPAVmed Inc. (PAVM) Q3 2022 Earnings Call TranscriptN/A
2022-11-15 06:12 ESTNewsPAVmed Q3 2022 Earnings PreviewN/A
2022-08-17 22:45 ESTNewsPAVmed extends losses despite Q2 earnings beatN/A
2022-08-17 05:22 ESTNewsPAVmed Non-GAAP EPS of -$0.17 beats by $0.03N/A
2022-08-17 05:22 ESTNewsPAVmed Inc. (PAVM) CEO Lishan Aklog on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-15 19:53 ESTNewsPAVmed Q2 2022 Earnings PreviewN/A
2022-08-13 15:46 ESTNewsStocks To Watch: Game Time For Walmart, Target, Lowe's And FuboTVN/A
2022-07-05 17:55 ESTNewsPAVmed Continues To Have Lots Of Potential But EsoGuard Determines Short-Term ProgressN/A
2022-05-12 22:48 ESTNewsPAVmed Non-GAAP EPS of -$0.14 beats by $0.05, revenue of $0.2M misses by $0.15MN/A
2022-05-12 22:47 ESTNewsPAVmed Inc.'s (PAVM) CEO Lishan Aklog on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-12 03:14 ESTNewsPAVmed Q1 2022 Earnings PreviewN/A
2022-03-30 05:37 ESTNewsPAVmed Non-GAAP EPS of -$0.15, revenue of $300MN/A
2022-03-30 05:36 ESTNewsPAVmed Inc. (PAVM) CEO Lishan Aklog on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-29 07:31 ESTNewsPAVmed Q4 2021 Earnings PreviewN/A
2022-03-24 20:21 ESTNewsPAVmed-Lucid esophageal precancer detection test in DOD funded studyN/A
2022-03-23 09:33 ESTNewsLucid Diagnostics launches test centers in 3 statesN/A
2022-03-17 18:29 ESTNewsPAVmed announces first human implants with the PortIO infusion systemN/A
2022-03-03 15:56 ESTNewsPAVmed unit Lucid acquires certain licenses/assets to operate new lab for EsoGuard testN/A
2022-02-24 17:01 ESTNewsPAVmed picks internal candidate for COO roleN/A
2021-12-24 13:45 ESTNewsStart Accumulating PAVmedN/A
2021-12-22 22:08 ESTNewsPAVmed falls 14% following $275M mixed shelf offeringN/A
2021-11-22 07:43 ESTNewsWarning: PAVM is at high risk of performing badlyN/A
2021-11-17 01:46 ESTNewsPAVmed lags consensus with early revenue estimates for Q3N/A
2021-11-17 01:46 ESTNewsPAVmed EPS in-line, misses on revenueN/A
2021-11-17 01:46 ESTNewsPAVmed down 10% after-hours on quarterly earningsN/A
2021-11-17 01:46 ESTNewsPAVmed Inc. (PAVM) CEO Lishan Aklog on Q3 2021 Results - Earnings Call TranscriptN/A
2021-10-07 16:42 ESTNewsPAVmed acquires EsophaCap manufacturer, CapNosticsN/A
2021-09-24 10:57 ESTNewsPAVmed Subsidiary, Lucid Diagnostics files IPO, terms undisclosedN/A
2021-09-22 02:59 ESTNewsPAVmed Inc. (PAVM) 5th Annual Best Ideas Growth (BIG5) Conference Presentation - SlideshowN/A
2021-08-23 13:22 ESTNewsPAVmed: Long Term Investment Case Remains Despite Weak Q2N/A
2021-08-13 18:46 ESTNewsPAVmed Inc. (PAVM) CEO Lishan Aklog on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-13 18:45 ESTNewsPAVmed sinks after Q2 revenue lagged estimatesN/A
2021-07-23 04:39 ESTNewsLucid Diagnostics inks strategic partnership with UpScriptHealthN/A
2021-07-21 19:08 ESTNewsPAVmed gets European CE Mark for Carpx minimally invasive carpal tunnel deviceN/A
2021-07-21 19:08 ESTNewsPAVmed's subsidiary receives CE mark for EsoCheck esophageal cell collection deviceN/A
2021-07-21 19:06 ESTNewsPAVmed forms digital health company, Veris HealthN/A
2021-07-21 19:01 ESTNewsPAVmed: A True Game-Changer For Medical Device InnovationN/A
2021-03-18 05:29 ESTFinancialsCompany financials have been released.Neutral
2021-03-09 02:34 ESTNewsPAVmed Primed To Deliver Significant Value For ShareholdersN/A
2021-02-26 05:23 ESTNewsPAVmed closes $45M capital raiseN/A

About PAVmed Inc (PAVM):

PAVmed Inc. operates as a medical device company in the United States. The company's lead product pipeline includes CarpX, a percutaneous device to treat carpal tunnel syndrome; EsoCheck, an non-invasive cell collection device and DNA biomarkers to detect esophageal cancer precursor; PortIO, an implantable intraosseous vascular access device; and DisappEAR, an antimicrobial resorbable ear tube. Its product pipeline also comprises NextCath, a self-anchoring catheter; NextFlo, a disposable infusion system; and Caldus, a disposable tissue ablation device. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was founded in 2014 and is based in New York, New York.

PAVM Quotes by TradingView

See Advanced Chart

General

  • Name PAVmed Inc
  • Symbol PAVM
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryMedical Devices
  • Full Time Employees 21
  • Fiscal Year EndDecember
  • IPO Date2016-04-28
  • Gic SectorHealth Care
  • Gic GroupHealth Care Equipment & Services
  • Gic IndustryHealth Care Equipment & Supplies
  • Gic SubIndustryHealth Care Equipment
  • Web URLhttp://www.pavmed.com
View More

Valuation

  • Price/Book (Most Recent Quarter) 17.73
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$0.41
  • Next Year EPS Estimate -$0.27
  • Next Quarter EPS Estimate -$0.12
  • Return on Assets -108%
  • Earnings Per Share -$0.65
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 377.67 million
  • EBITDA -12330859
  • PE Ratio -0.27
  • Analyst Target Price $7.42
  • Book Value Per Share -$0.11
View More

Share Statistics

  • Shares Outstanding 82.46 million
  • Shares Float 72.23 million
  • % Held by Insiders 1610%
  • % Held by Institutions 10.83%
  • Shares Short 5.57 million
  • Shares Short Prior Month 5.23 million
  • Short Ratio 0.9
  • Short % of Float 7%
  • Short % of Shares Outstanding 7%
View More

Technicals

  • Beta 0.29
  • 52 Week High $5.63
  • 52 Week Low $1.34
  • 50 Day Moving Average 3.59
  • 200 Day Moving Average 2.36
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

PAVmed Inc (PAVM) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

PAVmed Inc (PAVM) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-22$N/A-$0.17-$0.11-54.55%
2020-09-302020-11-06$N/A-$0.11-$0.11-3.09%
2020-06-302020-08-14$N/A-$0.13-$0.11-18.18%
2020-03-312020-04-09$N/A-$0.19-$0.11-72.73%
2019-12-312019-12-31$N/A-$0.19-$0.11-72.73%
2019-09-302019-11-19$N/A-$0.10-$0.100%
2019-06-302019-08-14$N/A-$0.13-$0.130%
2019-03-312019-05-15$N/A-$0.13-$0.130%
2018-12-312018-12-31$N/A-$0.15-$0.14-7.14%
2018-09-302018-11-14$N/A-$0.12-$0.120%
2018-06-302018-08-13$N/A-$0.26-$0.11-136.36%
2018-03-312018-05-21$N/A-$0.21-$0.15-40%
2017-09-302017-11-14$N/A-$0.40-$0.16-150%
2017-06-302017-08-11$N/A-$0.08-$0.1442.86%
2017-03-312017-05-22$N/A-$0.14-$0.140%
2016-12-312017-02-16$N/A-$0.13-$0.147.14%
2016-09-302016-11-10$N/A-$0.14-$0.156.67%
2016-06-302016-08-12$N/A-$0.10-$0.09-11.11%

PAVmed Inc (PAVM) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Research Development 3.64 million N/A N/A 2.63 million N/A
Income Before Tax -9.26 million N/A N/A -14.91 million N/A
Selling General Administrative 3.91 million N/A N/A 2.63 million N/A
Gross Profit N/A N/A N/A N/A N/A
Ebit -9.25 million N/A N/A -14.86 million N/A
Operating Income -7.56 million N/A N/A -5.25 million N/A
Income Tax Expense N/A N/A N/A N/A N/A
Total Revenue N/A N/A N/A N/A N/A
Cost of Revenue N/A N/A N/A N/A N/A
Total Other Income Expense Net -1.7 million N/A N/A -9.2 million N/A
Net Income From Continuing Operations -9.26 million N/A N/A -14.91 million N/A
Net Income Applicable to Common Shares N/A -5.56 million -5.65 million -14.55 million -6.31 million
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments N/A N/A -2000 N/A N/A
Change to Liabilities -440000 -510000 1.8 million 551667 373397
Total Cash Flow from Investing Activities -3000 -42000 -2000 -2145 N/A
Net Borrowings 6.83 million 3.95 million 6.16 million 6.21 million N/A
Total Cash Flow from Financial Activities N/A N/A 6.31 million N/A 67436
Change to Operating Activities -415000 -365000 -227000 132331 -341713
Change in Cash N/A N/A 2.51 million N/A -2.81 million
Total Cash from Operating Activities -5.84 million -5.56 million -3.79 million -4.09 million -2.88 million
Depreciation N/A N/A 3000 N/A 3779
Other Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Change to Inventory N/A N/A N/A N/A N/A
Change to Account Receivables N/A N/A N/A N/A N/A
Other Cash Flow from Financing Activities N/A N/A 5000 N/A N/A
Change to Net Income 490000 892000 9.1 million 2.28 million 171513
Capital Expenditures N/A N/A 2000 N/A N/A
Balance Sheet:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Total Liabailities 20.25 million N/A N/A 26.34 million N/A
Total Stockholder Equity 1.9 million N/A N/A -15 million N/A
Other Current Liabilities 54000 N/A N/A N/A N/A
Total Assets 19.78 million N/A N/A 10.11 million N/A
Common Stock N/A 50000 48000 44000 40479
Other Current Assets 855000 N/A N/A 133000 N/A
Retained Earnings -88.28 million -79.46 million -73.91 million -68.26 million -53.71 million
Other Liabilities N/A N/A N/A -1000 N/A
Other Assets N/A 724000 728000 691000 692937
Cash 17.26 million N/A N/A 8.73 million N/A
Total Current Liabilities 19.95 million 25.17 million N/A 26.34 million N/A
Other Stockholder Equity N/A N/A N/A 1000 N/A
Property, Plant & Equipment N/A N/A N/A N/A N/A
Total Current Assets 18.94 million 9.78 million N/A 9.42 million N/A
Long Term Investments N/A N/A N/A N/A N/A
Net Tangible Assets N/A -15.36 million -13.71 million -17.32 million -6.12 million
Short Term Investments N/A N/A N/A N/A N/A
Long Term Debt 300000 N/A N/A N/A N/A
Inventory N/A N/A N/A N/A N/A
Accounts Payable 2.97 million 3.21 million N/A 4.16 million N/A

PAVmed Inc (PAVM) Chart:

PAVmed Inc (PAVM) News:

Below you will find a list of latest news for PAVmed Inc (PAVM) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

PAVmed Inc (PAVM) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-172.50.07CALL0 620FALSE00
2024-05-1750CALL0 00FALSE00
2024-05-177.50CALL0 00FALSE00
2024-05-172.50PUT0 0118.03TRUE00
2024-05-1750PUT0 0328.58TRUE00
2024-05-177.50PUT0 0258.56TRUE00
2024-06-212.50.35CALL0 00FALSE00
2024-06-2150.22CALL0 110FALSE00
2024-06-217.50.05CALL0 60FALSE00
2024-06-212.50.67PUT0 4127.54TRUE00
2024-06-2153.02PUT0 1294.95TRUE00
2024-06-217.50PUT0 0481.87TRUE00
2024-09-202.51.33CALL0 30FALSE00
2024-09-2050.35CALL0 52123.19FALSE00
2024-09-207.50.05CALL3 7123.98FALSE00
2024-09-202.51.03PUT0 3132.68TRUE00
2024-09-2050PUT0 0150.79TRUE00
2024-09-207.50PUT0 0244.31TRUE00
2024-12-202.50CALL0 0149.75FALSE00
2024-12-2050CALL0 0121.87FALSE00
2024-12-207.50CALL0 00FALSE00
2024-12-202.50PUT0 0137.8TRUE00
2024-12-2050PUT0 0103.14TRUE00
2024-12-207.50PUT0 0156.23TRUE00

Latest PAVM Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST66$0.9372
Jun 13, 2022 7:59 PM EST62$0.9372
Jun 13, 2022 7:59 PM EST400$0.9372
Jun 13, 2022 7:59 PM EST15$0.9372
Jun 13, 2022 7:59 PM EST100$0.9372

PAVmed Inc (PAVM) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1624326/000149315220011323/0001493152-20-011323-index.htm
2018-10-12UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1624326/000000000018032181/0000000000-18-032181-index.htm
2019-09-26UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1624326/000000000019013984/0000000000-19-013984-index.htm
2019-10-03UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1624326/000000000019014244/0000000000-19-014244-index.htm
2019-12-19UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1624326/000000000019016593/0000000000-19-016593-index.htm
2020-01-22UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1624326/000000000020000555/0000000000-20-000555-index.htm
2020-02-18UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1624326/000000000020001503/0000000000-20-001503-index.htm
2020-09-14UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1624326/000000000020008631/0000000000-20-008631-index.htm
2018-06-25SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1624326/000101143818000148/0001011438-18-000148-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1624326/000101143819000063/0001011438-19-000063-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1624326/000101143820000095/0001011438-20-000095-index.htm
2018-07-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1624326/000109489118000152/0001094891-18-000152-index.htm
2018-07-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1624326/000109489118000154/0001094891-18-000154-index.htm
2018-07-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1624326/000109489118000156/0001094891-18-000156-index.htm
2018-08-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1624326/000109489118000164/0001094891-18-000164-index.htm
2019-02-045Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1624326/000109489119000046/0001094891-19-000046-index.htm
2019-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1624326/000109489119000084/0001094891-19-000084-index.htm
2019-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1624326/000109489119000085/0001094891-19-000085-index.htm
2019-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1624326/000109489119000086/0001094891-19-000086-index.htm
2019-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1624326/000109489119000087/0001094891-19-000087-index.htm
2019-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1624326/000109489119000088/0001094891-19-000088-index.htm
2019-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1624326/000109489119000089/0001094891-19-000089-index.htm
2019-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1624326/000109489119000092/0001094891-19-000092-index.htm
2019-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1624326/000109489119000093/0001094891-19-000093-index.htm
2019-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1624326/000109489119000121/0001094891-19-000121-index.htm
2019-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1624326/000109489119000123/0001094891-19-000123-index.htm
2020-05-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1624326/000109489120000065/0001094891-20-000065-index.htm
2020-05-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1624326/000109489120000066/0001094891-20-000066-index.htm
2020-05-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1624326/000109489120000068/0001094891-20-000068-index.htm
2020-05-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1624326/000109489120000070/0001094891-20-000070-index.htm
2020-05-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1624326/000109489120000074/0001094891-20-000074-index.htm
2020-05-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1624326/000109489120000076/0001094891-20-000076-index.htm
2020-05-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1624326/000109489120000078/0001094891-20-000078-index.htm
2020-05-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1624326/000109489120000080/0001094891-20-000080-index.htm
2018-06-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1624326/000114036118029763/0001140361-18-029763-index.htm
2018-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1624326/000114420418032917/0001144204-18-032917-index.htm
2018-06-11SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1624326/000114420418033787/0001144204-18-033787-index.htm
2018-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1624326/000114420418033789/0001144204-18-033789-index.htm
2018-07-06SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1624326/000114420418037575/0001144204-18-037575-index.htm
2018-05-24424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1624326/000149315218007732/0001493152-18-007732-index.htm
2018-06-01424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1624326/000149315218008104/0001493152-18-008104-index.htm
2018-06-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1624326/000149315218008404/0001493152-18-008404-index.htm
2018-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1624326/000149315218008524/0001493152-18-008524-index.htm
2018-06-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1624326/000149315218009312/0001493152-18-009312-index.htm
2018-07-06SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1624326/000149315218009778/0001493152-18-009778-index.htm
2018-08-10PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1624326/000149315218011391/0001493152-18-011391-index.htm
2018-08-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1624326/000149315218011526/0001493152-18-011526-index.htm
2018-08-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1624326/000149315218012480/0001493152-18-012480-index.htm
2018-08-24DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1624326/000149315218012541/0001493152-18-012541-index.htm
2018-10-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1624326/000149315218014004/0001493152-18-014004-index.htm
2018-10-05S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1624326/000149315218014163/0001493152-18-014163-index.htm
2018-10-15CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1624326/000149315218014478/0001493152-18-014478-index.htm
2018-10-18424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1624326/000149315218014598/0001493152-18-014598-index.htm
2018-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1624326/000149315218016081/0001493152-18-016081-index.htm
2018-12-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1624326/000149315218018004/0001493152-18-018004-index.htm
2019-01-09DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1624326/000149315219000337/0001493152-19-000337-index.htm
2019-01-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1624326/000149315219000455/0001493152-19-000455-index.htm
2019-01-25S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1624326/000149315219000959/0001493152-19-000959-index.htm
2019-02-14424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1624326/000149315219002077/0001493152-19-002077-index.htm
2019-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1624326/000149315219003192/0001493152-19-003192-index.htm
2019-03-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1624326/000149315219003615/0001493152-19-003615-index.htm
2019-04-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1624326/000149315219004603/0001493152-19-004603-index.htm
2019-04-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1624326/000149315219005118/0001493152-19-005118-index.htm
2019-04-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1624326/000149315219005217/0001493152-19-005217-index.htm
2019-04-15424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1624326/000149315219005247/0001493152-19-005247-index.htm
2019-04-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1624326/000149315219005466/0001493152-19-005466-index.htm
2019-04-19PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1624326/000149315219005667/0001493152-19-005667-index.htm
2019-04-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1624326/000149315219005816/0001493152-19-005816-index.htm
2019-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1624326/000149315219006165/0001493152-19-006165-index.htm
2019-05-08424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1624326/000149315219006561/0001493152-19-006561-index.htm
2019-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1624326/000149315219006562/0001493152-19-006562-index.htm
2019-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1624326/000149315219007219/0001493152-19-007219-index.htm
2019-05-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1624326/000149315219007446/0001493152-19-007446-index.htm
2019-05-20DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1624326/000149315219007777/0001493152-19-007777-index.htm
2019-05-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1624326/000149315219007884/0001493152-19-007884-index.htm
2019-05-22S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1624326/000149315219008077/0001493152-19-008077-index.htm
2019-06-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1624326/000149315219008789/0001493152-19-008789-index.htm
2019-06-25424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1624326/000149315219009664/0001493152-19-009664-index.htm
2019-06-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1624326/000149315219009665/0001493152-19-009665-index.htm
2019-06-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1624326/000149315219009776/0001493152-19-009776-index.htm
2019-07-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1624326/000149315219010639/0001493152-19-010639-index.htm
2019-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1624326/000149315219012534/0001493152-19-012534-index.htm
2019-09-30CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1624326/000149315219014758/0001493152-19-014758-index.htm
2019-09-3010-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1624326/000149315219014761/0001493152-19-014761-index.htm
2019-09-3010-Q/AQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1624326/000149315219014763/0001493152-19-014763-index.htm
2019-09-3010-Q/AQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1624326/000149315219014768/0001493152-19-014768-index.htm
2019-10-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1624326/000149315219015418/0001493152-19-015418-index.htm
2019-11-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1624326/000149315219016387/0001493152-19-016387-index.htm
2019-11-07DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1624326/000149315219016564/0001493152-19-016564-index.htm
2019-11-15NT 10-QNotification of inability to timely file Form 10-Q or 10-QSBhttps://www.sec.gov/Archives/edgar/data/1624326/000149315219017676/0001493152-19-017676-index.htm
2019-11-1910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1624326/000149315219017989/0001493152-19-017989-index.htm
2019-12-03S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1624326/000149315219018681/0001493152-19-018681-index.htm
2019-12-05DEL AMDelaying amendmenthttps://www.sec.gov/Archives/edgar/data/1624326/000149315219018779/0001493152-19-018779-index.htm
2020-01-08CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1624326/000149315220000374/0001493152-20-000374-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1624326/000149315220000502/0001493152-20-000502-index.htm
2020-01-30CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1624326/000149315220001396/0001493152-20-001396-index.htm
2020-02-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1624326/000149315220001909/0001493152-20-001909-index.htm
2020-02-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1624326/000149315220002639/0001493152-20-002639-index.htm
2020-02-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1624326/000149315220002766/0001493152-20-002766-index.htm
2020-03-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1624326/000149315220003191/0001493152-20-003191-index.htm
2020-03-02CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1624326/000149315220003240/0001493152-20-003240-index.htm
2020-03-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1624326/000149315220003574/0001493152-20-003574-index.htm
2020-03-30NT 10-KNotification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405https://www.sec.gov/Archives/edgar/data/1624326/000149315220005214/0001493152-20-005214-index.htm
2020-03-30S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1624326/000149315220005215/0001493152-20-005215-index.htm
2020-03-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1624326/000149315220005413/0001493152-20-005413-index.htm
2020-04-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1624326/000149315220005660/0001493152-20-005660-index.htm
2020-04-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1624326/000149315220006143/0001493152-20-006143-index.htm
2020-04-1410-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1624326/000149315220006405/0001493152-20-006405-index.htm
2020-04-15CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1624326/000149315220006461/0001493152-20-006461-index.htm
2020-04-20CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1624326/000149315220006775/0001493152-20-006775-index.htm
2020-04-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1624326/000149315220006812/0001493152-20-006812-index.htm
2020-04-2410-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1624326/000149315220007055/0001493152-20-007055-index.htm
2020-04-24CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1624326/000149315220007062/0001493152-20-007062-index.htm
2020-04-28424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1624326/000149315220007262/0001493152-20-007262-index.htm
2020-05-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1624326/000149315220007500/0001493152-20-007500-index.htm
2020-05-01DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1624326/000149315220007538/0001493152-20-007538-index.htm
2020-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1624326/000149315220008906/0001493152-20-008906-index.htm
2020-05-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1624326/000149315220009636/0001493152-20-009636-index.htm
2020-05-2810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1624326/000149315220010040/0001493152-20-010040-index.htm
2020-06-01PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1624326/000149315220010217/0001493152-20-010217-index.htm
2020-06-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1624326/000149315220010441/0001493152-20-010441-index.htm
2020-06-11DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1624326/000149315220010973/0001493152-20-010973-index.htm
2020-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1624326/000149315220010975/0001493152-20-010975-index.htm
2020-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1624326/000149315220011169/0001493152-20-011169-index.htm
2020-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1624326/000149315220011323/0001493152-20-011323-index.htm
2020-07-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1624326/000149315220014017/0001493152-20-014017-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1624326/000149315220014823/0001493152-20-014823-index.htm
2020-08-11DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1624326/000149315220015224/0001493152-20-015224-index.htm
2020-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1624326/000149315220015956/0001493152-20-015956-index.htm
2020-08-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1624326/000149315220016201/0001493152-20-016201-index.htm
2020-09-01S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1624326/000149315220017094/0001493152-20-017094-index.htm
2020-09-10S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1624326/000149315220017563/0001493152-20-017563-index.htm
2020-09-14CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1624326/000149315220017745/0001493152-20-017745-index.htm
2020-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1624326/000149315220020703/0001493152-20-020703-index.htm
2018-06-26SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1624326/000153561018000092/0001535610-18-000092-index.htm
2019-01-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1624326/000153561019000038/0001535610-19-000038-index.htm
2019-01-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1624326/000156761919001732/0001567619-19-001732-index.htm
2020-02-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1624326/000156761920001925/0001567619-20-001925-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1624326/000156761920011404/0001567619-20-011404-index.htm
2018-05-23EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1624326/999999999518001315/9999999995-18-001315-index.htm
2018-10-17EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1624326/999999999518002651/9999999995-18-002651-index.htm
2020-04-28EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1624326/999999999520000896/9999999995-20-000896-index.htm
2020-09-17EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1624326/999999999520002492/9999999995-20-002492-index.htm

PAVmed Inc (PAVM) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of PAVmed Inc (PAVM). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1610%
Institutional Ownership: 1083%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-04-30Lishan AklogChairman and CEOBuy250,000.001,098,413.00https://www.sec.gov/Archives/edgar/data/1624326/000109489120000066/0001094891-20-000066-index.htm
2020-05-29MATTHEW SIROVICH10% Share HolderSell131,082.001.98259,476.821,213,983.00https://www.sec.gov/Archives/edgar/data/1624326/000156761920011404/0001567619-20-011404-index.htm
2020-05-28MATTHEW SIROVICH10% Share HolderSell69,839.002.06143,665.811,345,065.00https://www.sec.gov/Archives/edgar/data/1624326/000156761920011404/0001567619-20-011404-index.htm
2018-06-08Ira Scott Greenspan10% Share HolderSell18,300.001.0419,032.00421,691.00https://www.sec.gov/Archives/edgar/data/1624326/000114420418033789/0001144204-18-033789-index.htm
2018-06-01Ira Scott Greenspan10% Share HolderSell532,255.000.97516,287.35439,991.00https://www.sec.gov/Archives/edgar/data/1624326/000114420418032917/0001144204-18-032917-index.htm
2019-03-15DENNIS M MCGRATHEVP & CFOBuy500,000.00524,000.00https://www.sec.gov/Archives/edgar/data/1624326/000109489119000092/0001094891-19-000092-index.htm
2019-05-24DENNIS M MCGRATHPresident & CFOBuy5,000.001.095,428.50529,000.00https://www.sec.gov/Archives/edgar/data/1624326/000109489119000123/0001094891-19-000123-index.htm
2018-08-28Lishan AklogChairman and CEOBuy30,000.001.1835,400.00618,413.00https://www.sec.gov/Archives/edgar/data/1624326/000109489118000164/0001094891-18-000164-index.htm
2020-04-30DENNIS M MCGRATHPresident & CFOBuy250,000.00791,704.00https://www.sec.gov/Archives/edgar/data/1624326/000109489120000065/0001094891-20-000065-index.htm
2019-03-15Lishan AklogChairman and CEOBuy200,000.00818,413.00https://www.sec.gov/Archives/edgar/data/1624326/000109489119000093/0001094891-19-000093-index.htm
2019-05-23Lishan AklogChairman and CEOBuy30,000.001.1032,850.00848,413.00https://www.sec.gov/Archives/edgar/data/1624326/000109489119000121/0001094891-19-000121-index.htm